Purchase Order W81XWH21P0146
Award Date 7/27/21
Potential Completion Date 10/14/21
Potential Value $394K
Funding Federal Agency
Contracting Federal Agency
Awardee
Ultimate Awardee
Not listed NAICS Category
PSC Category
Set-Aside Type
No Set-Aside Used
Federal Contract Vehicle
- Not listed
Extent Competed
Not Competed
Major Defense Program
Not listed Pricing Type
Firm Fixed Price
Place of Performance
Frederick, MD 21702, USA
Solicitation Procedures
Only One Source
Number Of Offers Received
1
Legislative Mandate
Not listed National Interest Action
Not listed Research Type
Not listed Primary Consortia Member
Not listed Similar Awards
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp for the supply of Artesunate 110 mg vials under a firm fixed-price contract valued at $41,572.62. The delivery order, issued on May 2, 2025, with an ultimate completion date of May 5, 2025, represents a direct procurement of this antimalarial pharmaceutical product for federal medical supply needs. This award is unset-aside and was competitively awarded through the vendor's existing indefinite delivery...
- This delivery order, awarded by the Defense Logistics Agency to Amerisourcebergen Drug Corporation, has a potential value of one hundred five thousand six hundred eighty-five dollars and seventy-six cents ($105,685.76) to supply four hundred fifty-six thousand two hundred forty-eight thousand nine hundred ninety-four (4562489499) units of artesunate, a medication used to treat malaria, in one hundred ten (110) milligram vials. The contract has a firm fixed price and period of performance through...
- The U.S. Defense Logistics Agency's Medical Supply Chain awarded a delivery order valued at $6,928.76 to AmerisourceBergen Drug Corp for the supply of Artesunate 110 mg vials. This competitive delivery order, issued on May 27, 2025, with completion expected by May 28, 2025, represents a firm fixed price transaction with no set-aside designation. AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania, serves as a critical federal vendor for...
- The U.S. Defense Medical Supply Chain awarded a $5,859 delivery order to AmerisourceBergen Drug Corp for Malarone 250/100 (100 tablets), a pharmaceutical antimalarial medication. This competitively awarded, firm fixed-price contract has an ultimate completion date of September 16, 2025, and represents a child delivery order under AmerisourceBergen's larger Indefinite Delivery Contract with the Defense Logistics Agency. The work will be performed at the contractor's corporate office in...
- The Defense Logistics Agency awarded a delivery order valued at $13,673.47 to AmerisourceBergen Drug Corp for Atovaquone-Proguanil 250-100, a pharmaceutical product typically used for malaria prevention and treatment. The contract was awarded on September 16, 2025, with a completion date of September 17, 2025, and employs firm fixed-price pricing with no set-aside designation, indicating competitive award. The work will be performed at AmerisourceBergen's corporate office location in...
- This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $2,978.95 firm fixed-price delivery order is for the supply of Atovaquone-Proguanil 250-100 100s, a pharmaceutical product used for the prevention and treatment of malaria. The award is part of a larger $999,999,999 Indefinite Delivery Contract (IDC) held by AmerisourceBergen with the DLA Troop Support Medical,...
- The Defense Logistics Agency awarded a $22,386 firm fixed price delivery order to AmerisourceBergen Drug Corp for 100 units of Atovaquone-Proguanil 250-100, an antimalarial medication commonly used by military personnel for malaria prophylaxis. The delivery order, issued on August 1, 2025, with an ultimate completion date of August 4, 2025, represents a non-competitive award under the company's existing indefinite delivery contract with DLA. AmerisourceBergen Drug Corp, headquartered in...
- This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $3,711.18 firm fixed-price delivery order is for the supply of Atovaquone-Proguanil 250-100 100s, a medication used for the prevention and treatment of malaria. The contract has an ultimate completion date of September 15, 2022 and was awarded on September 14, 2022. It is not designated as a set-aside contract....
- The Defense Logistics Agency awarded a delivery order valued at $1,922.76 to AmerisourceBergen Drug Corp for Atovaquone-Proguanil 250-100 100s, a antimalarial medication commonly used for malaria prophylaxis and treatment in military personnel and Department of Defense beneficiaries. The contract, awarded on July 29, 2025, with an ultimate completion date of July 30, 2025, represents a firm fixed price procurement with no set-aside designation, indicating competitive award to this qualified...
- The Defense Logistics Agency (DLA) awarded a $5,267.04 delivery order to AmerisourceBergen Drug Corp for 100 units of Atovaquone-Proguanil 250-100, an antimalarial medication commonly used for malaria prevention and treatment in military populations. This firm fixed-price delivery order, awarded September 3, 2025, with completion targeted for September 4, 2025, represents a non-competitive set-aside contract awarded through open competition. AmerisourceBergen Drug Corp, headquartered in...